These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4891306)

  • 41. Are heparins anti-neoplastic agents?
    Douketis JD; Lloyd NS
    Pol Arch Med Wewn; 2007; 117(11-12):491-3. PubMed ID: 18363247
    [No Abstract]   [Full Text] [Related]  

  • 42. Heparin and CXCL12 dimerization.
    Altundag K; Altundag O; Atik MA
    J Clin Oncol; 2005 Oct; 23(28):7248. PubMed ID: 16192624
    [No Abstract]   [Full Text] [Related]  

  • 43. Guidelines on the use and monitoring of heparin.
    Baglin T; Barrowcliffe TW; Cohen A; Greaves M;
    Br J Haematol; 2006 Apr; 133(1):19-34. PubMed ID: 16512825
    [No Abstract]   [Full Text] [Related]  

  • 44. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venous thromboembolism in oncology.
    Falanga A; Vignoli A
    Eksp Onkol; 2004 Mar; 26(1):11-4. PubMed ID: 15112573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thromboembolic complications in children with cancer.
    Wiernikowski JT; Athale UH
    Thromb Res; 2006; 118(1):137-52. PubMed ID: 16039698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development in anticoagulant therapy.
    van Doormaal FF; Büller HR; Middeldorp S
    Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The physiologic coagulation fibrinolytic system of the body and thrombohemorrhagic theory in oncology].
    Nadiradze ISh; Machabeli MS
    Usp Fiziol Nauk; 1989; 20(4):94-109. PubMed ID: 2688336
    [No Abstract]   [Full Text] [Related]  

  • 49. Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
    Sud R; Khorana AA
    Thromb Res; 2009; 123 Suppl 4():S18-21. PubMed ID: 19303497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [On anticoagulant prophylaxis in blood vessel surgery].
    Deutschinoff A; Dimitroff D; Genoff I
    Z Gesamte Inn Med; 1966 Apr; 21(7):219-21. PubMed ID: 5985210
    [No Abstract]   [Full Text] [Related]  

  • 51. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
    Lee AY
    Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267
    [No Abstract]   [Full Text] [Related]  

  • 52. Thromboprophylaxis during chemotherapy after advanced cancer.
    Agnelli G; Verso M
    Thromb Res; 2007; 120 Suppl 2():S128-32. PubMed ID: 18023706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
    Falanga A; Marchetti M; Vignoli A; Balducci D
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombosis and cancer.
    Arkel YS
    Semin Oncol; 2000 Jun; 27(3):362-74. PubMed ID: 10864223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Concern about the safety of erythropoietin in cancer patients].
    van der Lelie J
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):920-2. PubMed ID: 18561786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of thrombosis in ambulatory patients with cancer.
    Rana P; Levine MN
    J Clin Oncol; 2009 Oct; 27(29):4885-8. PubMed ID: 19752331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.
    Saxena AK; Panhotra BR; Sundaram DS; Morsy MN; Al-Ghamdi AM
    Nephrology (Carlton); 2006 Aug; 11(4):299-305. PubMed ID: 16889569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of the coagulation system in cancerogenesis and metastasation.
    Xie WZ; Leibl M; Clark MR; Dohrmann P; Kunze T; Gieseler F
    Biomed Pharmacother; 2005 Apr; 59(3):70-5. PubMed ID: 15795099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin as an anticancer therapeutic.
    Zacharski LR; Lee AY
    Expert Opin Investig Drugs; 2008 Jul; 17(7):1029-37. PubMed ID: 18549339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determining the anti-coagulant-independent anti-cancer effects of heparin.
    Solari V; Jesudason EC; Turnbull JE; Yates EA
    Br J Cancer; 2010 Aug; 103(4):593-4. PubMed ID: 20648011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.